mHealth devices are becoming ever more common among patient engagement initiatives, allowing physicians and nurses to monitor patients even from a distance and improve the quality of care along the treatment timeline.
Recently, mHealth Intelligence reported that researchers from North Carolina State University are developing a ‘bandage reader’ that, when applied to the skin, will be able to monitor the oxygen levels of a patient’s tissue in real time.
The project is funded by the federal government with $1.5 million going toward developing the device for treatment of peripheral artery disease (PAD). The device will integrate with Profusa’s Lumee Oxygen Platform, which monitors tissue oxygen levels. Natalie Wisniewski, PhD, Profusa’s chief technology officer, spoke to the collaboration’s importance in a press release:
The goal of our collaboration is to develop a bandage-like version of Profusa’s first-generation optical reader that is flexible, disposable, and conforms to the foot for continuous monitoring of tissue oxygen levels during revascularization and restenosis in patients with PAD … The impact of our alliance has the potential to be transformative, not just for PAD, but for the broad field of mobile health monitoring.
With further advancements being developed every day, the mHealth landscape is an exciting place to be. We look forward to sharing more stories like this one!